Glossary >
Clinical Trial Diversity

Clinical Trial Diversity

The intentional inclusion of participants from different racial, ethnic, gender, age, socioeconomic, and geographic backgrounds in clinical research. Clinical trial diversity ensures that study results reflect the real-world population and that treatments are safe and effective for everyone. Acclinate advances clinical trial diversity by building trusted relationships with underrepresented communities, using data-driven outreach tools, and supporting sponsors in meeting FDA and NIH diversity guidance. Achieving diversity in research isn't just a regulatory goal—it's a moral and scientific imperative that drives better outcomes and greater equity in healthcare innovation.